Drug intelligence / Profile preview

HKIIM-KU formula

Development stage: Phase 2
Lead developer: The Chinese University of Hong Kong
Modality: Small Molecules
Administration: Oral

Overview

HKIIM-KU formula is an innovative Chinese herbal medicine formulation developed and used in Hong Kong for the treatment of gout. It has been observed to be effective in relieving and preventing gout and its related clinical manifestations, such as joint swelling, pain, and movement disorders. The mechanism of action is not fully elucidated but is believed to involve analgesic (pain-relieving), anti-inflammatory, and uric acid-lowering effects. The formulation is currently being evaluated in a double-blind, randomized, placebo-controlled multicenter clinical trial led by the Chinese University of Hong Kong[3][4][9].

Other names: HKIIM-KU formulaInnovative Chinese Herbal Formula for the Treatment of Gout

Beyond the preview

Go deeper on HKIIM-KU formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HKIIM-KU formula.

Explore the full profile